Ulcerative colitis (UC) is a chronic inflammatory disorder with limited effective therapeutic options for long-term treatment and disease maintenance. We hypothesized that a multi-cohort analysis of independent cohorts representing real-world heterogeneity of UC would identify a robust transcriptomic signature to improve identification of FDA-approved drugs that can be repurposed to treat patients with UC.
Author(s): Bai, Lawrence, Scott, Madeleine K D, Steinberg, Ethan, Kalesinskas, Laurynas, Habtezion, Aida, Shah, Nigam H, Khatri, Purvesh
DOI: 10.1093/jamia/ocab165